FFFMX | NBHCX | FFFMX / NBHCX | |
Total Expense Ratio | 0.32 | 1.84 | 17% |
Annual Report Gross Expense Ratio | 0.32 | 1.84 | 17% |
Fund Existence | 4 years | 17 years | - |
Gain YTD | -1.070 | 2.795 | -38% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 97.3B | 937M | 10,384% |
Annual Yield % from dividends | 1.89 | 0.97 | 195% |
Returns for 1 year | 4.51 | 4.41 | 102% |
Returns for 3 years | 11.66 | -3.92 | -298% |
Returns for 5 years | N/A | 31.33 | - |
Returns for 10 years | N/A | 15.13 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VNSE | 31.44 | 1.23 | +4.09% |
Natixis Vaughan Nelson Select ETF | |||
EMCB | 65.23 | 1.21 | +1.89% |
WisdomTree Emerging Markets Corp Bd ETF | |||
EWX | 56.15 | 0.81 | +1.46% |
SPDR® S&P Emerging Markets Small Cap ETF | |||
PBE | 61.11 | 0.87 | +1.45% |
Invesco Biotechnology & Genome ETF | |||
PGX | 11.07 | 0.07 | +0.64% |
Invesco Preferred ETF |